Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revvity, Inc. Common Stock (NY:RVTY)

155.35 +4.41 (+2.92%)
Delayed Quote Updated: 11:13 AM EDT, Oct 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revvity, Inc. Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
(RVTY) - Analyzing Revvity's Short Interest ↗
 
Via Benzinga
News headline image
Forecasting The Future: 7 Analyst Projections For Revvity ↗
 
Via Benzinga
News headline image
Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing
From Revvity
Via Business Wire
News headline image
Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance
From Revvity
Via Business Wire
News headline image
These Analysts Revise Their Forecasts On Revvity Following Q3 Results ↗
 
Via Benzinga
News headline image
Assessing Revvity: Insights From 8 Financial Analysts ↗
 
Via Benzinga
News headline image
Revvity Announces FDA Clearance for First Automated Free Testosterone Test
From Revvity
Via Business Wire
News headline image
Revvity to Present at J.P. Morgan Healthcare Conference
From Revvity
Via Business Wire
News headline image
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst ↗
BofA upgrades Danaher and Revvity, predicting a mixed but improving outlook for life sciences tools in fiscal year 2025 amid ongoing market challenges. 
Via Benzinga
News headline image
Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK
From Revvity
Via Business Wire
News headline image
Looking Into Revvity's Recent Short Interest ↗
 
Via Benzinga
News headline image
Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells
From Scale Biosciences
Via Business Wire
News headline image
Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference
From Revvity
Via Business Wire
News headline image
Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation
From Revvity
Via Business Wire
News headline image
4 Analysts Have This To Say About Revvity ↗
 
Via Benzinga
News headline image
Revvity Announces Financial Results for the Third Quarter of 2024
From Revvity
Via Business Wire
News headline image
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
News headline image
Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories
From Revvity
Via Business Wire
News headline image
Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report
From Revvity
Via Business Wire
News headline image
Revvity To Hold Earnings Call on Monday, November 4, 2024
From Revvity
Via Business Wire
News headline image
Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene
From Revvity
Via Business Wire
News headline image
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
News headline image
Wall Street Rises Ahead Of Big Tech Earnings, Fed Meeting; Tesla Rebounds, Oil Prices Drop To 7-Week Lows: What's Driving Markets Monday? ↗
Wall Street opened higher at the start of a data-heavy week, with traders adopting an optimistic tone ahead of crucial earnings reports and economic events. 
Via Benzinga
Topics Economy
News headline image
RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q2 2024 ↗
RVTY stock results show that Revvity beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Life Science Firm Revvity Lifts Annual Profit Forecast On Strong Q2 Performance ↗
Revvity reported Q2 sales of $691.69 million, surpassing estimates, with adjusted EPS of $1.22. Life Sciences revenue fell 7%, while Diagnostics sales rose 1%. Updated 2024 guidance includes sales of... 
Via Benzinga
News headline image
Revvity Announces Financial Results for the Second Quarter of 2024
From Revvity
Via Business Wire
News headline image
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
News headline image
Revvity To Hold Earnings Call on Monday, July 29, 2024
From Revvity
Via Business Wire
News headline image
Revvity to Present at Goldman Sachs Global Healthcare Conference
From Revvity
Via Business Wire
News headline image
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday? ↗
U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc.... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.